// App-Quantinova.ai

: Safety and Efficacy of 52 Weeks' Therapy with Hydroxychloroquine (HCQ)—First Anti-inflammatory Drug Approved in India for T2D

Researchers

Presenter

  • ANIL PAREEK

Principal Investigators

  • RAVI TEJRAJ MEHTA

  • SHRUTI DHARMADHIKARI

Medical Centers

  • N/A

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Metformin Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • IV

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved